Zdrowie i gospodarka · 03/12/2025

FDA Announces Draft Guidance for Streamlining Monoclonal Antibody Nonclinical Safety Studies

The FDA has released a draft guidance to help industry sponsors reduce animal testing for monoclonal antibodies, aiming to minimize the use of non-human primates and align with the 3R principles of reducing, refining, and replacing animal testing.